Main

Bristol-Myers Squibb Plans To Build Biologics Facility In The U.S.


Bristol-Myers Squibb Plans To Build Biologics Facility In The U.S. (PharmaceuticalOnline)
Bristol-Myers Squibb Company said recently that it will build its new biologics facility in the United States

Crucell and DSM Biologics Announce PER.C6(R) Licensing Agreement With UMN


Crucell and DSM Biologics Announce PER.C6(R) Licensing Agreement With UMN Pharma (RedNova)
Leiden/Sittard, The Netherlands, March 9, 2006 - Dutch biotechnology company Crucell N.V.
 
Notify me with the latest breaking FDA News
fda approvals Tell us where to send your notifications:

(AFX UK Focus) 2006-03-07 20:55 GMT: Pfizer eyes generic biologics


(AFX UK Focus) 2006-03-07 20:55 GMT: Pfizer eyes generic biologics market (Interactive Investor)
BOSTON (AFX) -- Pfizer vice-chairman David Shedlarz said Tuesday that his company is considering using its vast manufacturing capacity to enter the emerging generic biologics market.

 

©2006 FDA-News.com. All rights reserved.